SynthesisPeerJ2026
The optimal dose of brisk walking for improving blood pressure in hypertensive patients: a systematic review and bayesian meta-analysis of randomized controlled trials.
Synthesis in PeerJ, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hypertension is one of the most common chronic diseases worldwide. Brisk walking is regarded as a safe and effective exercise modality for blood pressure reduction; however, its optimal exercise dose remains unclear. This study aims to systematically evaluate the effects of brisk walking on blood pressure in patients with hypertension using a Bayesian meta-analysis, and to determine the dose-response relationship and the optimal exercise dose range. Methods: Randomized controlled trials (RCTs) were systematically searched in China National Knowledge Infrastructure (CNKI), VIP Information (VIP), Wanfang Data, CBM, PubMed, EBSCO (MEDLINE), Embase, the Cochrane Library, and Web of Science from database inception to December 30, 2025. Bayesian hierarchical random-effects models were constructed using the brms, metafor, and dosresmeta packages in R software (version 4.4.3) to perform pairwise comparisons and dose-response meta-analyses. The risk of bias was assessed using the Cochrane Risk of Bias 2 (RoB 2) tool. Results: A total of 17 RCTs involving 1,493 patients with hypertension were included. Brisk walking significantly reduced systolic blood pressure (Hedges' g = - 0.48, 95% CrI [-0.54 to -0.43]) and diastolic blood pressure (Hedges' g = - 0.51, 95% CrI [-0.58 to -0.44]), both representing moderate effect sizes. A "U" shaped dose-response relationship was observed for systolic blood pressure, with the optimal dose at approximately 460 MET (Metabolic Equivalent) ⋅ min/week (Hedges' g = - 1.00, 95% CrI [-1.54 ∼-0.46]), indicating a large effect size. Diastolic blood pressure exhibited a negative dose-response relationship, with the most significant improvement also observed at approximately 620 MET min/week (Hedges ' g = - 0.55, 95% CrI [-1.06 ∼-0.03]), corresponding to a substantial effect. Conclusion: Brisk walking significantly improves blood pressure in patients with hypertension and demonstrates a precise dose-response relationship. A brisk walking regimen of four sessions per week, ≤ 40 minutes per session, lasting at least 12 weeks, with a total weekly dose of 460-620 MET min/week, is recommended to achieve the most pronounced blood pressure-lowering effects.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.